Cargando…

An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries

BACKGROUND: Noncommunicable diseases (NCDs), including mental health, have become a major concern in low- and middle-income countries. Despite increased attention to them over the past decade, progress toward addressing NCDs has been slow. A lack of bold policy commitments has been suggested as one...

Descripción completa

Detalles Bibliográficos
Autores principales: Jailobaeva, Kanykey, Falconer, Jennifer, Loffreda, Giulia, Arakelyan, Stella, Witter, Sophie, Ager, Alastair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240078/
https://www.ncbi.nlm.nih.gov/pubmed/34187499
http://dx.doi.org/10.1186/s12992-021-00713-4
_version_ 1783715144983904256
author Jailobaeva, Kanykey
Falconer, Jennifer
Loffreda, Giulia
Arakelyan, Stella
Witter, Sophie
Ager, Alastair
author_facet Jailobaeva, Kanykey
Falconer, Jennifer
Loffreda, Giulia
Arakelyan, Stella
Witter, Sophie
Ager, Alastair
author_sort Jailobaeva, Kanykey
collection PubMed
description BACKGROUND: Noncommunicable diseases (NCDs), including mental health, have become a major concern in low- and middle-income countries. Despite increased attention to them over the past decade, progress toward addressing NCDs has been slow. A lack of bold policy commitments has been suggested as one of the contributors to limited progress in NCD prevention and management. However, the policies of key global actors (bilateral, multilateral, and not-for-profit organisations) have been understudied. METHODS: This study aimed to map the key global actors investing in action regarding NCDs and review their policies to examine the articulation of priorities regarding NCDs. Narrative synthesis of 70 documents and 31 policy papers was completed, and related to data collated from the Global Health Data Visualisation Tool. RESULTS: In 2019 41% of development assistance for health committed to NCDs came from private philanthropies, while that for other global health priorities from this source was just 20%. Through a range of channels, bilateral donors were the other major source of NCD funding (contributing 41% of NCD funding). The UK and the US were the largest bilateral investors in NCDs, each contributing 8%. However, NCDs are still under-prioritised within bilateral portfolios – receiving just 0.48% of US funding and 1.66% of the UK. NGOs were the key channels of funding for NCDs, spending 48% of the funds from donors in 2019. The reviewed literature generally focused on NCD policies of WHO, with policies of multilateral and bilateral donors given limited attention. The analysis of policies indicated a limited prioritisation of NCDs in policy documents. NCDs are framed in the policies as a barrier to economic growth, poverty reduction, and health system sustainability. Bilateral donors prioritise prevention, while multilateral actors offer policy options for NCD prevention and care. Even where stated as a priority, however, funding allocations are not aligned. CONCLUSION: The growing threat of NCDs and their drivers are increasingly recognised. However, global actors’ policy priorities and funding allocations need to align better to address these NCD threats. Given the level of their investment and engagement, more research is needed into the role of private philanthropies and NGOs in this area. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12992-021-00713-4.
format Online
Article
Text
id pubmed-8240078
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82400782021-06-29 An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries Jailobaeva, Kanykey Falconer, Jennifer Loffreda, Giulia Arakelyan, Stella Witter, Sophie Ager, Alastair Global Health Research BACKGROUND: Noncommunicable diseases (NCDs), including mental health, have become a major concern in low- and middle-income countries. Despite increased attention to them over the past decade, progress toward addressing NCDs has been slow. A lack of bold policy commitments has been suggested as one of the contributors to limited progress in NCD prevention and management. However, the policies of key global actors (bilateral, multilateral, and not-for-profit organisations) have been understudied. METHODS: This study aimed to map the key global actors investing in action regarding NCDs and review their policies to examine the articulation of priorities regarding NCDs. Narrative synthesis of 70 documents and 31 policy papers was completed, and related to data collated from the Global Health Data Visualisation Tool. RESULTS: In 2019 41% of development assistance for health committed to NCDs came from private philanthropies, while that for other global health priorities from this source was just 20%. Through a range of channels, bilateral donors were the other major source of NCD funding (contributing 41% of NCD funding). The UK and the US were the largest bilateral investors in NCDs, each contributing 8%. However, NCDs are still under-prioritised within bilateral portfolios – receiving just 0.48% of US funding and 1.66% of the UK. NGOs were the key channels of funding for NCDs, spending 48% of the funds from donors in 2019. The reviewed literature generally focused on NCD policies of WHO, with policies of multilateral and bilateral donors given limited attention. The analysis of policies indicated a limited prioritisation of NCDs in policy documents. NCDs are framed in the policies as a barrier to economic growth, poverty reduction, and health system sustainability. Bilateral donors prioritise prevention, while multilateral actors offer policy options for NCD prevention and care. Even where stated as a priority, however, funding allocations are not aligned. CONCLUSION: The growing threat of NCDs and their drivers are increasingly recognised. However, global actors’ policy priorities and funding allocations need to align better to address these NCD threats. Given the level of their investment and engagement, more research is needed into the role of private philanthropies and NGOs in this area. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12992-021-00713-4. BioMed Central 2021-06-29 /pmc/articles/PMC8240078/ /pubmed/34187499 http://dx.doi.org/10.1186/s12992-021-00713-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jailobaeva, Kanykey
Falconer, Jennifer
Loffreda, Giulia
Arakelyan, Stella
Witter, Sophie
Ager, Alastair
An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries
title An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries
title_full An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries
title_fullStr An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries
title_full_unstemmed An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries
title_short An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries
title_sort analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240078/
https://www.ncbi.nlm.nih.gov/pubmed/34187499
http://dx.doi.org/10.1186/s12992-021-00713-4
work_keys_str_mv AT jailobaevakanykey ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries
AT falconerjennifer ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries
AT loffredagiulia ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries
AT arakelyanstella ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries
AT wittersophie ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries
AT ageralastair ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries
AT jailobaevakanykey analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries
AT falconerjennifer analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries
AT loffredagiulia analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries
AT arakelyanstella analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries
AT wittersophie analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries
AT ageralastair analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries